Inventor
REES DAVID CHARLES
GB19 patents
⚠️ This page may combine multiple inventors who share the name “REES DAVID CHARLES”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ASTEX THERAPEUTICS LTD
9 patentsUS9464071B2Oct 11, 2016
Pyrazolyl quinoxaline kinase inhibitors
ASTEX THERAPEUTICS LTD24 citations93
US9850228B2Dec 26, 2017
Pyrazolyl quinoxaline kinase inhibitors
ASTEX THERAPEUTICS LTD17 citations91
US9458158B2Oct 4, 2016
Bicyclic heterocycle compounds and their uses in therapy
ASTEX THERAPEUTICS LTD11 citations84
US8013163B2Sep 6, 2011
4-(2,6-dichloro-benzoylamino)-1H-pyrazole-3-carboxylic acid piperidin-4-ylamide acid addition salts as kinase inhibitors
ASTEX THERAPEUTICS LTD7 citations83
US10544132B2Jan 28, 2020
Isoindolinone inhibitors of the MDM2-p53 interaction having anticancer activity
ASTEX THERAPEUTICS LTD10 citations82
US10526311B2Jan 7, 2020
Isoindolinone inhibitors of the MDM2-P53 interaction having anticancer activity
ASTEX THERAPEUTICS LTD6 citations82
US11261171B1Mar 1, 2022
Isoindolinone inhibitors of the MDM2-P53 interaction having anticancer activity
ASTEX THERAPEUTICS LTD2 citations71
US10981898B2Apr 20, 2021
Isoindolinone inhibitors of the MDM2-p53 interaction having anticancer activity
ASTEX THERAPEUTICS LTD4 citations71
US12071429B2Aug 27, 2024
Isoindolinone inhibitors of the MDM2-P53 interaction having anticancer activity
ASTEX THERAPEUTICS LTD0 citations60